Latest Product Launch News

ReNerve Limited is scaling up its clinical trial for the NervAlign® Nerve Cuff following promising interim results that show significant pain reduction in nerve repair patients. The expanded study aims to solidify evidence for broader regulatory approval and market adoption.

Nanosonics Limited has announced a $20 million on-market share buy-back program for FY26, underscoring its robust financial health and confidence in future growth driven by new product innovations.

Galan Lithium has completed a $20 million strategic placement with Clean Elements, fully funding Phase 1 construction of its Hombre Muerto West lithium project in Argentina, with production on track for mid-2026.

City Chic Collective reports solid revenue growth driven by a 10% increase in ANZ sales and a resilient, profitable US business despite tariff challenges.

Orthocell has completed its first Remplir™ surgical case in Hong Kong, marking a pivotal step in its Asian commercialisation strategy. The launch at the Hong Kong Orthopaedic Association Congress and partnership with MontsMed set the stage for broader regional growth.

Pure Foods Tasmania reported a $1 million operating cash outflow in the September quarter due to restructuring and timing factors but anticipates positive cash flow and growth driven by new Coles product launches and operational efficiencies.

RMA Global Limited kicked off FY26 with a robust 21% increase in recurring revenue, driven by the rollout of Curated Social and a strategic pivot to target US brokerages exclusively. The company’s new Social Studio platform is gaining traction across the US, Australia, and New Zealand.

WA Kaolin Ltd has reported a record-breaking quarter in sales volume and revenue, driven by operational enhancements and expanding market reach across Asia and domestic sectors.

Acrux Limited reports robust revenue growth in Q1 FY26, driven by strong profit share income from recently launched topical pharmaceuticals and a significant R&D tax rebate repayment.

FirstWave Cloud Technology reports a cash-flow positive quarter with a $2.85 million capital raise and advances its AI-powered compliance product, targeting a commercial release by November.

Hydralyte USA reported a 6% year-on-year sales increase in Q3 FY25 alongside a significant 42% reduction in operating cash burn, driven by a streamlined US-focused model and new product launches in brain and gut health.

Visionflex Group has converted $3.25 million of debt into equity at a 100% premium, emerging debt-free and poised for growth. The company’s Q1 FY26 results show a 34% increase in annual recurring revenue, supported by new product launches targeting the expanding virtual healthcare market.